Treatment.com International Inc
CNSX:TRUE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Treatment.com International Inc
Cash & Cash Equivalents
Treatment.com International Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Treatment.com International Inc
CNSX:TRUE
|
Cash & Cash Equivalents
CA$1.2m
|
CAGR 3-Years
10%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Teladoc Health Inc
NYSE:TDOC
|
Cash & Cash Equivalents
$781.1m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
30%
|
|
|
CorVel Corp
NASDAQ:CRVL
|
Cash & Cash Equivalents
$230m
|
CAGR 3-Years
43%
|
CAGR 5-Years
12%
|
CAGR 10-Years
24%
|
|
|
Alignment Healthcare LLC
NASDAQ:ALHC
|
Cash & Cash Equivalents
$575.8m
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Accolade Inc
NASDAQ:ACCD
|
Cash & Cash Equivalents
$185.9m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
Privia Health Group Inc
NASDAQ:PRVA
|
Cash & Cash Equivalents
$479.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Treatment.com International Inc
Glance View
Treatment.com International, Inc. engages in the research and development, business development of consumer health services delivered by mobile app technology. The company is headquartered in Bloomington, Minnesota. The company went IPO on 2021-04-19. The firm has developed an artificial intelligence (AI) platform to help patients and caregivers around the globe to make better health decisions. The firm offers treatment digital health application, which is driven by an intelligent digital health assistant that allows people to take control of their health. The company is a revolutionary symptom assessment tool. Its treatment mobile app provides specialist-level symptom checking, integrated medication logistics, and personalized curated assessments based on the individual user. The Company’s solutions include treatment clinical and treatment commercial. Its treatment clinical solutions include global library of medicine (GLM), treatment intelligent digital assistant, treatment triage, treatment dermatology, treatment ophthalmology and treatment medical education. Its treatment commercial solutions include rewards distribution, membership, and social network.
See Also
What is Treatment.com International Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.2m
CAD
Based on the financial report for Dec 31, 2024, Treatment.com International Inc's Cash & Cash Equivalents amounts to 1.2m CAD.
What is Treatment.com International Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
19%
Over the last year, the Cash & Cash Equivalents growth was 72%. The average annual Cash & Cash Equivalents growth rates for Treatment.com International Inc have been 10% over the past three years , 19% over the past five years .
